In-hospital COVID-19 infection echocardiographic analysis: a Brazilian, tertiary single-centre experience
Autor: | Lucas Arraes de França, Carolina Stangenhaus, Juliana Cardoso Dória Dantas, Rodrigo A. C. Meirelles, Samira Saady Morhy, Tania Regina Afonso, Claudio Henrique Fischer, Rafael Bonafim Piveta, Andrea Paula Lins Ponchirolli, Rodrigo Cordovil Pinto L. da Costa, Alessandra Joslin Oliveira, Miguel O. D. Aguiar, Adriana Cordovil, Wercules Oliveira, Alessandro Cavalcanti Lianza, Sergio Barros-Gomes, Marcelo Luiz Campos Vieira, Líria Maria Lima da Silva, Patrícia O. Roveri, Lara A. S. Martins, Edgar Daminelo |
---|---|
Rok vydání: | 2021 |
Předmět: |
Male
Renal failure medicine.medical_specialty medicine.medical_treatment Diastole Pericardial effusion Internal medicine medicine Humans Diseases of the circulatory (Cardiovascular) system Radiology Nuclear Medicine and imaging Prospective Studies Myocardial infarction Prospective cohort study Angiology Mechanical ventilation Mortality pulmonary thromboembolism Ejection fraction SARS-CoV-2 business.industry Research COVID-19 General Medicine Prognosis medicine.disease Hospitals medicine.anatomical_structure Echocardiography Ventricle RC666-701 Cardiology Cardiology and Cardiovascular Medicine business Brazil |
Zdroj: | Cardiovascular Ultrasound, Vol 19, Iss 1, Pp 1-10 (2021) Cardiovascular Ultrasound |
ISSN: | 1476-7120 |
DOI: | 10.1186/s12947-021-00265-y |
Popis: | Background Information is lacking concerning in-hospital echocardiography analysis of COVID-19 infection in Brazil. We evaluated echocardiographic parameters to predict a composite endpoint of mortality, pulmonary thromboembolism or acute renal failure. Methods A prospective full echocardiographic study of consecutive patients hospitalized with COVID-19, single tertiary centre in Brazil. We correlated echocardiographic findings to biomarkers, clinical information, thoracic tomography, and in-hospital composite endpoint of mortality, pulmonary thromboembolism or renal failure. Results One hundred eleven patients from March to October 2020, 67 ± 17 years, 65 (58.5%) men, death was observed in 21/111 (18.9%) patients, 48 (43%) required mechanical ventilation, myocardial infarction occurred in 10 (9%), pulmonary thromboembolism in 7 (6.3%) patients, haemodialysis was required for 9 (9.8%). Echocardiography was normal in 51 (46%) patients, 20 (18%) presented with decreased left ventricle ejection, 18 (16.2%) had abnormal left ventricle global longitudinal strain, 35 (31%) had diastolic dysfunction, 6 (5.4%) had an E/e’ratio > 14, 19 (17.1%) presented with right ventricle dilated/dysfunction, 31 (28%) had pericardial effusion. The echocardiographic parameters did not correlate with mortality, biomarkers, clinical events. Tricuspid velocity was related to the composite endpoint of mortality, pulmonary thromboembolism or acute renal failure (p: 00.3; value: 2.65 m/s; AUC ROC curve: 0.739; sensitivity: 73.3; specificity: 66.7; CI: 0.95, inferior: 0.613; superior: 0,866). Conclusions Among hospitalized patients with COVID-19, echocardiography was normal in 51(46%) patients, and 20 (18%) patients presented with a decreased left ventricle ejection fraction. Tricuspid velocity was related to the composite endpoint of mortality, pulmonary thromboembolism or acute renal failure. |
Databáze: | OpenAIRE |
Externí odkaz: |